Tagrisso 80 mg Tablet

Product Details

Tagrisso 80 mg Tablet – Advanced Therapy for Lung Cancer

Tagrisso 80 mg Tablet contains Osimertinib, a targeted therapy used in the treatment of specific types of lung cancer, particularly Non-Small Cell Lung Cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. This medication works by inhibiting EGFR activity, helping slow or stop the growth of cancer cells.

Uses:

• Non-Small Cell Lung Cancer (NSCLC):
  • Treatment of EGFR T790M mutation-positive metastatic NSCLC.
  • First-line treatment for patients with EGFR exon 19 deletions or exon 21 (L858R) mutations.

How Tagrisso 80 mg Tablet Works:

Osimertinib is a third-generation EGFR tyrosine kinase inhibitor (TKI) that selectively binds to mutant EGFRs. It inhibits EGFR signaling pathways responsible for tumor growth and progression, leading to improved outcomes in NSCLC patients.

Common Side Effects:

• Diarrhea
• Rash or dry skin
• Fatigue
• Nail changes
• Decreased appetite
• Stomatitis (mouth sores)

Serious Side Effects (Seek Immediate Medical Attention):

• Lung problems such as interstitial lung disease (ILD)
• Heart complications, including QT prolongation
• Severe skin reactions
• Eye issues, such as blurred vision or eye pain

Key Features:

• Contains Osimertinib, a highly effective EGFR inhibitor.
• Specifically designed for patients with certain EGFR mutations.
• Oral tablet for easy administration.
• Shown to improve survival rates and quality of life in lung cancer patients.

Precautions:

• Pregnancy and Breastfeeding: Not recommended during treatment due to potential harm to the fetus or infant.
• Heart Monitoring: Regular monitoring of heart function is advised.
• Lung Health: Monitor for symptoms of lung issues such as cough or difficulty breathing.
• Drug Interactions: Inform your doctor about any medications you are taking.

Frequently Asked Questions (FAQ):

Q. What is Tagrisso 80 mg Tablet used for?
Tagrisso is primarily used to treat Non-Small Cell Lung Cancer (NSCLC) with specific EGFR mutations, including T790M-positive metastatic NSCLC.

Q. How long should I take Tagrisso 80 mg Tablet?
The duration of treatment depends on your doctor’s recommendation, based on disease progression and tolerance to the medication.

Q. Can Tagrisso 80 mg Tablet cure lung cancer?
Tagrisso is not a cure but an advanced therapy to manage and control the disease, prolong survival, and improve quality of life in NSCLC patients.

Q. Is Tagrisso 80 mg Tablet safe during pregnancy?
No, it is not safe during pregnancy. Women of childbearing potential should use effective contraception during treatment and for some time after stopping the medication.

References:

1. Tagrisso (Osimertinib) Product Information – https://www.medicines.org.uk/emc/product/7615/pil
2. Osimertinib Overview –https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208065s021lbl.pdf